Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06681428

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Led by Tides Medical · Updated on 2025-02-10

240

Participants Needed

9

Research Sites

104 weeks

Total Duration

On this page

Sponsors

T

Tides Medical

Lead Sponsor

P

Professional Education and Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.

CONDITIONS

Official Title

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 18 years old
  • Have a Wagner Grade 1 diabetic foot ulcer extending through the skin below the medial malleolus
  • If multiple ulcers of the same grade are present, the largest ulcer will be studied; other ulcers on the same foot must be at least 2 cm away
  • Ulcer present for more than 4 weeks but less than 1 year before consent
  • Ulcer size between 1.0 cm² and 25 cm² at screening and treatment visits
  • Adequate circulation to the affected foot within 3 months before screening, confirmed by specified vascular tests
  • Ulcer offloaded for at least 14 days before treatment visit
  • Females of childbearing potential agree to use birth control and have pregnancy tests during the study
  • Willing and able to participate in weekly visits
  • Signed informed consent form before screening
Not Eligible

You will not qualify if you...

  • Ulcer caused by a medical condition other than diabetes
  • Ulcer suspected to be cancerous requiring biopsy
  • Infected ulcer
  • History of immune-suppressant treatment, chemotherapy, or topical steroids within one month before screening or anticipated during study
  • Use of investigational drugs or devices within 30 days before screening
  • History of radiation therapy at the ulcer site
  • Ulcer previously treated or needing prohibited therapies
  • Diagnosis of HIV or Hepatitis C
  • Conditions that severely affect ability to complete the study or poor medical adherence history
  • Osteomyelitis or bone infection in affected foot within 30 days before screening
  • Pregnant or breastfeeding
  • Poor diabetes control with HbA1c over 12.0 within last 90 days
  • End stage renal disease with serum creatinine ≥3.0 mg/dL within 6 months before enrollment
  • Acute Charcot Neuroarthropathy in affected limb
  • Ulcer area reduced by 30% or more after 14 days of standard care from screening to randomization visit

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Limb Preservation Platform Inc

Fresno, California, United States, 93710

Actively Recruiting

2

Angel City Research

Los Angeles, California, United States, 90010

Actively Recruiting

3

Clemente Clinical Research

Los Angeles, California, United States, 90033

Actively Recruiting

4

ILD Research Center

Vista, California, United States, 92081

Actively Recruiting

5

Clever Medical Research

Miami, Florida, United States, 33126

Actively Recruiting

6

Foot and Ankle Specialists of the Mid-Atlantic

Raleigh, North Carolina, United States, 27609

Actively Recruiting

7

Lower Extremity Institute of Research and Therapy

Boardman, Ohio, United States, 44512

Actively Recruiting

8

Brock Liden DPM

Circleville, Ohio, United States, 43113

Actively Recruiting

9

Foot and Ankle Specialists of the Mid-Atlantic

Salem, Virginia, United States, 24153

Actively Recruiting

Loading map...

Research Team

F

Frank Burrows III, MBA, EMT, BCMAS, CWCA

CONTACT

M

Mora Melican, PH.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here